Eledon Pharmaceuticals Statistics
Total Valuation
ELDN has a market cap or net worth of $235.50 million. The enterprise value is $102.80 million.
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026, after market close.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ELDN has 75.97 million shares outstanding. The number of shares has increased by 68.42% in one year.
| Current Share Class | 75.85M |
| Shares Outstanding | 75.97M |
| Shares Change (YoY) | +68.42% |
| Shares Change (QoQ) | +24.26% |
| Owned by Insiders (%) | 0.06% |
| Owned by Institutions (%) | 54.18% |
| Float | 68.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.71 |
| P/TBV Ratio | 2.26 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.40, with a Debt / Equity ratio of 0.00.
| Current Ratio | 7.40 |
| Quick Ratio | 7.30 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -35.79% and return on invested capital (ROIC) is -6,771.13%.
| Return on Equity (ROE) | -35.79% |
| Return on Assets (ROA) | -30.04% |
| Return on Invested Capital (ROIC) | -6,771.13% |
| Return on Capital Employed (ROCE) | -55.26% |
| Weighted Average Cost of Capital (WACC) | 8.85% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.38M |
| Employee Count | 33 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ELDN has paid $35,000 in taxes.
| Income Tax | 35,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.38% in the last 52 weeks. The beta is 0.84, so ELDN's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | +4.38% |
| 50-Day Moving Average | 2.59 |
| 200-Day Moving Average | 2.58 |
| Relative Strength Index (RSI) | 60.20 |
| Average Volume (20 Days) | 1,452,355 |
Short Selling Information
The latest short interest is 8.42 million, so 11.08% of the outstanding shares have been sold short.
| Short Interest | 8.42M |
| Short Previous Month | 6.46M |
| Short % of Shares Out | 11.08% |
| Short % of Float | 12.25% |
| Short Ratio (days to cover) | 7.67 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -83.25M |
| Pretax Income | -45.58M |
| Net Income | -45.62M |
| EBITDA | n/a |
| EBIT | -83.25M |
| Earnings Per Share (EPS) | -$0.56 |
Full Income Statement Balance Sheet
The company has $133.34 million in cash and $641,000 in debt, with a net cash position of $132.70 million or $1.75 per share.
| Cash & Cash Equivalents | 133.34M |
| Total Debt | 641,000 |
| Net Cash | 132.70M |
| Net Cash Per Share | $1.75 |
| Equity (Book Value) | 136.78M |
| Book Value Per Share | 1.81 |
| Working Capital | 117.34M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -62.34M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -62.34M |
| FCF Per Share | -$0.82 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ELDN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -68.42% |
| Shareholder Yield | -68.42% |
| Earnings Yield | -19.37% |
| FCF Yield | -26.47% |
Analyst Forecast
The average price target for ELDN is $8.50, which is 174.19% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.50 |
| Price Target Difference | 174.19% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | 9.52% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 5, 2020. It was a reverse split with a ratio of 1:18.
| Last Split Date | Oct 5, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:18 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |